Kristy Roberts
Family Medicine · Conway, ARNPI 1578534012
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 591 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 44 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,698 and has fallen 68.5% since, to $535 in 2025. Among family medicine clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 591 payments — averaging $15.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$1K
- AstraZeneca$785
- Lilly USA, LLC$735
- GSK$649
- Pfizer$595
- plus $4K from 38 others
What the payments were for
- Food & beverage$8,878100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$8,878 in reported general payments places this provider in the 90th percentile of 1,347 family medicine providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 89 | $94,367 |
| OzempicSemaglutide | 84 | $87,093 |
| EliquisApixaban | 87 | $68,024 |
| FarxigaDapagliflozin Propanediol | 70 | $49,159 |
| JardianceEmpagliflozin | 46 | $48,509 |
| RybelsusSemaglutide | 35 | $44,330 |
| LinzessLinaclotide | 35 | $27,417 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $19,651 |
| XareltoRivaroxaban | 26 | $17,491 |
| GemtesaVibegron | 34 | $16,344 |
| Spiriva RespimatTiotropium Bromide | 15 | $7,828 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $6,118 |
| MyrbetriqMirabegron | 13 | $5,738 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 37 | $4,796 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $4,264 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,161 | $131,423119 claims |
| Lilly USA, LLCMounjaro | $735 | $94,36789 claims |
| PfizerEliquis | $595 | $68,02487 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Pradaxa | $247 | $58,63972 claims |
| AstraZenecaFarxiga, Symbicort | $785 | $53,42386 claims |
| AbbVieLinzess, Synthroid | $1,145 | $28,43054 claims |
| GSKTrelegy Ellipta | $649 | $19,65130 claims |
| Johnson & JohnsonXarelto | $241 | $17,49126 claims |
| Astellas Pharma US IncMyrbetriq | $18 | $5,73813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,347 family medicine providers in Arkansas.
Other family medicine in Conway
- Thad HardinConway$18K
- David NaylorConway$17K
- Lander SmithConway$16K
- Joe CumminsConway$15K
- John DicksonConway$15K
- Michael CarsonConway$14K
- Randal BowlinConway$11K
- Glenn GibbonsFort Smith$179K
- Hetal PatelParagould$147K
- David GersonSherwood$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.